Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02983617 · COMPLETED
Trial details
- NCT number
- NCT02983617
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2019-02-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.